Biomea Fusion (BMEA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

BMEA Biomea Fusion

Watchlist

4.010
+0.090+2.30%

Close Jan 7 16:00 ET

145.32MMarket Cap-1.00P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study
GlobeNewswireJan 7 09:00 ET
Here's Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks to Buy Under $10
Yahoo FinanceJan 6 09:04 ET
Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswireJan 6 07:00 ET
Biomea Fusion Advances Diabetes Treatment With Positive Study Results
TipRanksDec 20, 2024 15:27 ET
Truist Financial Maintains Biomea Fusion(BMEA.US) With Buy Rating
Moomoo NewsDec 18, 2024 09:33 ET · Ratings
A Quick Look at Today's Ratings for Biomea Fusion(BMEA.US), With a Forecast Between $11 to $50
Moomoo NewsDec 18, 2024 08:00 ET · Ratings

Comments

我要向钱看

19 hours ago

NEW PRECLINICAL DATA

$Biomea Fusion (BMEA.US)$ New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass compared to semaglutide alone
Icovamenib, in combination with semaglutide, approximately doubled C-peptide production per unit of glucose compared to semaglutide alone leading to a 60% improved reduction of fasting blood glucose
Ex vivo human islet experiments pr...

我要向钱看

19 hours ago

UPDATES

$Biomea Fusion (BMEA.US)$ REDWOOD CITY, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced today that Thomas Butler, Chief Executive Officer and Chairman of the Board, will present at the 43rd Annual J.P. Morgan Healthcare Confer...

Moo Top

19 hours ago

Pump and Dump..

$Biomea Fusion (BMEA.US)$ $Biomea Fusion (BMEA.US)$

Trytosaveabit

19 hours ago

Update

$Biomea Fusion (BMEA.US)$ Reuters· 3 mins ago
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study Thanks @Jaguar8 For spotting since for some reason they say no more posts???

我要向钱看

Jan 6 06:07

UPDATES

$Biomea Fusion (BMEA.US)$ Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Heat List

Overall

No Data